CD4 T-cell immunotherapy targeting MAGE-A3 is safe, and shows early clinical responses

New investigational targeted therapeutic, entrectinib, shows early promise

Paediatric and adult high grade gliomas: A tale of a histone tail

Galectins in tumour immunity

Treatment of relapsed myeloma with novel targeted and immune therapies

Targeting T regs in tumours

Integrating multiple omics information in the era of precision oncology

Direct activation of STING in the tumour microenvironment leads to potent and systemic tumour regression and immunity

Successes and challenges in designing combination immunotherapy clinical trials for breast cancer

Understanding personalised medicine - the e-learning course

Physical activity may improve prostate cancer prognosis

Inflammatory microenvironment regulates colorectal cancer progression